How do the prices of 7 common procedures vary by site of care? 5 insights
Price differentials by site of care for common procedures exist at the national level, and are increasing over time, according to a study published in the American Journal of Managed Care.
Game Changers: Consumerism and Price Sensitivity Are Set to Change the Health Care Marketplace
Price Sensitivity: A Fundamental Economic Principle
Consider 3 patients coming to the pharmacy, each with a generic prescription retailing for $100. The first has a $10 co-payment, the second has 10% coinsurance, and the third has a high-deductible plan with a health savings account. The first patient pays $10 and happily leaves the pharmacy. The second patient pays $10, but only after asking the pharmacist if he thought the medication worked well.
Scripps Study Uses Wearable Sensors to Detect Strokes
Image credit: STSI
Researchers at the Scripps Translational Science Institute (STSI) have launched a home-based clinical trial that uses wearable sensor technology to identify people with asymptomatic atrial fibrillation (AFib). STSI is a National Institutes of Health sponsored consortium led by Scripps Health in collaboration with The Scripps Research Institute.
Keeping data – and people – healthy
Things have changed quickly and dramatically in the healthcare industry – by necessity. The Affordable Care Act has allowed millions of Americans to gain health insurance. Global health initiatives are also improving health and raising the bar for healthcare around the world.
CVS Health Research Institute Study Demonstrates Impact of Prescription Refill Programs on Medication Adherence
WOONSOCKET, R.I., Nov. 16, 2015 /PRNewswire/ — New research by the CVS Health Research Institute is the first to show the impact of prescription refill programs on medication adherence. The study, published in the American Journal of Managed Care, found that ReadyFill®, the refill program available at CVS/pharmacy®, improved adherence to medications for common chronic conditions without …
U.S. drug benefit managers clamp down on specialty pharmacies
(Reuters) — In recent days, the largest U.S. managers of private prescription drug benefits have cut off at least eight pharmacies that work closely with drugmakers, intensifying scrutiny of a system that helps inflate drug prices, officials at the pharmacy benefit managers told Reuters.
Nearly half of hepatitis C patients on medicaid denied coverage for life-saving drugs
Nearly 50 percent of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they weren’t considered “a medical necessity” or because the patients tested positive for alcohol/drugs, among other reasons, according to new research.
- Industry News